Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

DARPA Awards Up to $10.7 Million Contract to RxMP Therapeutics for Development of RMP-402.

Oct 20, 2026

Contract Type

contract

MiamiBiotechnologyHealth CareTherapeuticsPharmaceutical

Description

RxMP Therapeutics, Inc. has been awarded a contract of up to $10.7 million from DARPA to support the development and manufacturing scale-up of RMP-402. The funding is essential for completing preclinical and regulatory milestones necessary for the product's advancement toward clinical trials.

Company Information

Company

RxMP Therapeutics

Location

Miami, Florida, United States

About

RxMP Therapeutics is a pharmaceutical company focused on developing proprietary drugs for the management of excessive bleeding. The Company aims to develop and commercialize RMP-HPE, (red cell-derived microparticles produced by high-pressure extrusion), as a new hemostatic agent for the treatment or prevention of excessive bleeding. The Company's first product candidate, RMP-402, is a hemostatic agent derived from red blood cells, designed to prevent and treat excessive bleeding by enhancing platelet function and coagulation without causing off-target clotting.

Related People

Shawna
Likely contact at this company
••••••••@••••••••

See Shawna's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for RxMP Therapeutics's next move

Learn about Strategic plan

RxMP Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.